ABOUT™—Dependence (ABOUT™—Dependence)

Philip Morris Products S.A.

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

WEBINAR: An Author Webinar on the ABOUT™ Toolbox - Recorded session available here!


Philip Morris has launched an ongoing collaborative effort to develop fit-for-purpose measurement instruments (i.e., concept-driven instruments providing interpretable outcomes for the purpose intended) to enhance the scientific framework of harm reduction. This new initiative has resulted in the creation of the ABOUT™ Toolbox (Assessment of Behavioral OUtcomes related to Tobacco and nicotine products). The ABOUT™ Toolbox currently comprises five measurement instruments that are at various stages of development and validation.

The ABOUT™—Dependence is a self-report instrument designed to measure the perceived dependence associated with the use of tobacco and nicotine-containing products (TNPs), including smoke-free products (e.g. heated tobacco products, e-cigarettes, Nicotine Replacement Therapy products (NRTs), smokeless tobacco) and combustible products (e.g. cigarettes, cigars/cigarillos). The measurement of dependence on TNPs has primarily focused on assessing product-specific dependence (notably cigarette dependence) rather than overall dependence associated with the use of one or more TNPs. The ABOUT™—Dependence was developed to provide a measure of perceived psychological dependence associated with the use of different TNPs and across exclusive and multiple TNPs users.

More details are available on www.pmiscience.com


Philip Morris Products S.A.

Philip Morris Products S.A. (Switzerland)
© 2018 Philip Morris Products S.A. All rights reserved

For more information regarding the ABOUT™—Dependence, please contact Mapi Research Trust, the official distributor of the questionnaire.
To assess the perceived dependence associated with the use of a wide range of tobacco and nicotine-containing products
Therapeutic area
  • Behavior and Behavior Mechanisms
Therapeutic indication
  • Smoking
  • Smoking Cessation
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Chrea C, Acquadro C, Afolalu EF, Spies E, Salzberger T, Abetz-Webb L, Cano S, Arnould B, Mainy N, Rose J, Weitkunat R. Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT™ Toolbox initiative. F1000Res. 2018 Dec 2;7:1878 (Full text article)

Chrea C, Salzberger T, Abetz-Webb L. Development of a Tobacco and Nicotine Products Dependence Instrument. Society for Research on Nicotine & Tobacco. 24th Annual Meeting. 2018 Feb (Full text article)

Chrea C, Salzberger T, Abetz-Webb L. Development of a fit-for-purpose tobacco and nicotine product dependence instrument. ISPOR Europe. 2018 Nov (Full text article)

Chrea C, Salzberger T, Abetz-Webb L. Psychometric validation of the ABOUT-Dependence : A Fit-for-purpose instrument to assess global dependence on tobacco and nicotine products. Society for Research on Nicotine & Tobacco. 25th Annual Meeting. 2019 Feb (Full text article)

Salzberger T, Cano S, Abetz-Webb L, Afolalu E, Chrea C, Weitkunat R, Fagerström K, Rose J. Addressing traceability in social measurement: establishing a common metric for dependence. Journal of Physics: Conference Series. 2019 Nov; 1379(1):012024 (Full text article)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use


Philip Morris Products S.A.

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, academic users, healthcare organizations

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.


Original language(s)

  • English for the USA


The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.


Czech for Czech Republic*
English for the UK
German for Germany*
Greek for Greece*
Italian for Italy*
Japanese for Japan*
Korean for Korea*
Portuguese for Portugal*
Romanian for Romania*
Russian for Russia*
Russian for Ukraine*
Ukrainian for Ukraine*
* Performed by Mapi/ICON

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us